A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma.

Qingqing Li, Tong Su,Xu Zhang,Yanfeng Pan,Shengli Ma, Lu Zhang, Xianqiang Zhang,Xiaojuan Gao

Cancer management and research（2022）

引用 1|浏览3

暂无评分

摘要

Anlotinib is effective and well-tolerated as a first-line treatment for patients with aHCC. Treatment with TKIs and PD-1 inhibitors after disease progression has also shown preliminary efficacy and safety; therefore, sequential therapy with anlotinib-TKIs and PD-1 inhibitors may be an effective treatment for patients with aHCC.

查看译文

关键词

anlotinib,hepatocellular carcinoma,real world,sequential therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要